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Abstract 23 
Equine laminitis, a disease of the lamellar structure of the horse’s hoof, can be incited 24 
by numerous factors that include inflammatory and metabolic aetiologies. However, 25 
the role of inflammation in hyperinsulinaemic laminitis has not been adequately 26 
defined. Toll-like receptor (TLR) activation results in up-regulation of inflammatory 27 
pathways and the release of pro-inflammatory cytokines, including interleukin-6 (IL-6) 28 
and tumour necrosis factor-alpha (TNF-α), and may be a pathogenic factor in 29 
laminitis. The aim of this study was to determine whether TLR4 expression and 30 
subsequent pro-inflammatory cytokine production is increased in lamellae and 31 
skeletal muscle during equine hyperinsulinaemia. Standardbred horses were treated 32 
with either a prolonged, euglycaemic hyperinsulinaemic clamp (p-EHC) or a 33 
prolonged, glucose infusion (p-GI), which induced marked and moderate 34 
hyperinsulinaemia, respectively. Age-matched control horses were treated 35 
simultaneously with a balanced electrolyte solution. Treated horses developed clinical 36 
(p-EHC) or subclinical (p-GI) laminitis, whereas controls did not. Skeletal muscle and 37 
lamellar protein extracts were analysed by Western blotting for TLR4, IL-6, TNF-α 38 
and suppressor of cytokine signaling 3 (SOCS3) expression. Lamellar protein 39 
expression of TLR4 and TNF-α, but not IL-6, was increased by the p-EHC, compared 40 
to control horses. A significant positive correlation was found between lamellar TLR4 41 
and SOCS3. Skeletal muscle protein expression of TLR4 signaling parameters did not 42 
differ between control and p-EHC-treated horses. Similarly, the p-GI did not result in 43 
up-regulation of lamellar protein expression of any parameter. The results suggest that 44 
insulin-sensitive tissues may not accurately reflect lamellar pathology during 45 
hyperinsulinaemia. While TLR4 is present in the lamellae, its activation appears 46 
unlikely to contribute significantly to the developmental pathogenesis of 47 
 3 
hyperinsulinaemic laminitis. However, inflammation may have a role to play in the 48 
later stages (e.g., repair or remodelling) of the disease. 49 
 50 
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1. Introduction 53 
 54 
Hyperinsulinaemia, usually occurring in association with equine metabolic syndrome 55 
and insulin resistance (IR), has been shown to be a causative and prognostic factor for 56 
laminitis in horses (de Laat et al., 2010; McGowan et al., 2004; Treiber et al., 2006). 57 
Damage to the lamellar (dermo-epidermal) interface in the horse’s hoof can result in 58 
structural changes, such as distal phalanx disorientation and lameness, both of which 59 
are defining features of laminitis (Pollitt, 2004). In addition to hyperinsulinaemia, 60 
many diverse inciting causes of laminitis have been identified and differing 61 
aetiopathologies for the disease may exist (Katz and Bailey, 2012). Despite the name, 62 
an obvious inflammatory profile has not been identified for all forms of laminitis. 63 
Although studies on laminitis occurring in association with dietary carbohydrate 64 
overload (CHO) have identified increases in infiltrating leukocytes (de Laat et al., 65 
2011b; Faleiros et al., 2011) and lamellar pro-inflammatory cytokine gene expression 66 
(Budak et al., 2009; Leise et al., 2011), studies on inflammatory markers during 67 
hyperinsulinaemic laminitis are limited.  68 
 69 
Examinations of whole body markers of inflammation in ponies prone to laminitis 70 
have yielded disparate results. Ponies with a history of pasture-associated laminitis 71 
have been shown to have elevated plasma concentrations of the pro-inflammatory 72 
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cytokine tumour necrosis factor -alpha (TNF-α) in some studies, but not in others 73 
(Carter et al., 2009; Treiber et al., 2009; Wray et al., 2012). However, interpretation of 74 
these results is complicated by obesity, since increased adiposity has been associated 75 
with a chronic inflammatory state in both humans and animals (Shi et al., 2006; Tanti 76 
et al., 2012; Wakshlag et al., 2011; Wellen and Hotamisligil, 2005). Importantly, the 77 
use of a prolonged, euglycaemic hyperinsulinaemic clamp (p-EHC) technique has 78 
facilitated the examination of the effects of hyperinsulinaemia in horses without the 79 
complications of IR and obesity (Asplin et al., 2011; de Laat et al., 2011a; de Laat et 80 
al., 2012a; Suagee et al., 2011a; Suagee et al., 2011b). Insulin infusions used to 81 
induce marked hyperinsulinaemia have resulted in pro-inflammatory cytokine release 82 
in both humans and horses, indicating that hyperinsulinaemia itself may contribute to 83 
inflammation (Soop et al., 2002; Stegenga et al., 2008; Suagee et al., 2011a). The p-84 
EHC also causes laminitis in horses and ponies, thereby allowing investigation of 85 
lamellar pathology induced by hyperinsulinaemia (Asplin et al., 2007; de Laat et al., 86 
2010). Therefore, the p-EHC will allow further investigation of whether inflammation 87 
is a pathogenic factor during hyperinsulinaemic laminitis, as it appears to be in other 88 
forms of the disease.   89 
 90 
Toll-like receptor (TLR) signaling is central to the pathophysiology of inflammation 91 
(Devaraj et al., 2011). Essential in regulation of the innate immune system, activation 92 
of TLR signaling results in up-regulation of inflammatory pathways and the release of 93 
pro-inflammatory cytokines including interleukin-6 (IL-6) and TNF-α (Könner and 94 
Brüning, 2011). Evidence for functional TLR signaling has been demonstrated in the 95 
horse (DeClue et al., 2012). By recruiting immune cells in the face of pathogen 96 
invasion, TLRs have been shown to be of central importance in stimulating 97 
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inflammatory responses; however, they are also activated by endogenous ligands 98 
(Dasu et al., 2012). In particular, in addition to its primary ligand lipopolysaccharide 99 
(LPS), signaling mediated by TLR4 can be activated by free fatty acids (Devaraj et al., 100 
2009). As such, this member of the TLR family, which is abundantly located in 101 
insulin-sensitive tissue, plays a key role in linking metabolism and inflammation 102 
(Könner and Brüning, 2011; Reyna et al., 2008). In horses, up-regulation of TLR 103 
signaling on monocytes has been demonstrated to be a pathogenic factor during 104 
inflammation (Kwon et al., 2010), however, whether activation of TLR-4 and its 105 
subsequent pro-inflammatory cytokine production is linked to the pathogenesis of 106 
laminitis in horses is unknown. 107 
 108 
The aim of the current study was to determine whether TLR4 expression and 109 
subsequent pro-inflammatory cytokine production is increased in lamellae and 110 
skeletal muscle during marked and moderate equine hyperinsulinaemia, induced with 111 
a p-EHC or a prolonged, glucose infusion (p-GI), respectively. 112 
 113 
2. Materials and Methods 114 
 115 
2.1. Subjects and techniques 116 
 117 
Archived lamellar and skeletal muscle samples obtained from previous studies were 118 
used for the current study (de Laat et al., 2010; de Laat et al., 2012c). Briefly, healthy 119 
Standardbred horses (n = 15) of similar age (5.83 ± 0.5 years) and bodyweight (423.3 120 
± 11.5 kg) were allocated at random to three groups. One group (n = 4) was treated 121 
with a p-EHC to induce marked exogenous hyperinsulinaemia and Obel grade 2 122 
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laminitis (Obel, 1948). A second group (n = 4) was treated with a prolonged, glucose 123 
infusion (p-GI) to induce moderate endogenous hyperinsulinaemia and subclinical 124 
lamellar pathology. The third group consisted of control horses (n = 7) that were 125 
randomly paired with treated horses (one control horse was matched to two p-GI 126 
treated horses).  127 
 128 
The p-EHC was administered as a constant rate infusion of insulin to induce 129 
hyperinsulinaemia (1036 ± 129 µIU/ml) (Humulin-R (Eli-Lily, NSW, Australia; 6 130 
mIU/kg BW/min) combined with 50% dextrose (Baxter, NSW, Australia) given at a 131 
variable rate to ensure euglycaemia (~5 mmol/L) until the onset of Obel grade 2 132 
laminitis (de Laat et al., 2010). During the p-GI, 50% dextrose (0.68 mL/kg/h) was 133 
administered as a constant rate infusion to induce hyperglycaemia (10.7 ± 0.8 mmol/L) 134 
and moderate hyperinsulinaemia (208 ± 26 μIU/mL) (de Laat et al., 2012c). Control 135 
horses were treated with a balanced electrolyte solution (Hartmanns (Baxter, NSW, 136 
Australia), 0.57 mL/kg/h) for the same period as their matched treated horse (p-EHC: 137 
46 ± 2.3 h, p-GI: 48 h). Matched control horses did not experience any changes in 138 
insulin (10.0 ± 0.9 µIU/mL) or glucose (5.5 ± 0.3 mmol/L) concentrations during 139 
infusion of the balanced electrolyte solution, nor develop any lamellar pathology. 140 
 141 
Following humane euthanasia, lamellar tissue specimens from the dorsal mid-section 142 
of the hoof (5 mm x 5 mm) were collected from all horses and mid gluteal muscle 143 
samples (10 mm x 10 mm) were collected from the p-EHC group and their matched 144 
controls. Tissue samples were rinsed in ice-cold ddH2O before being rapidly frozen in 145 
liquid nitrogen and stored at -80ºC until processed.  146 
 147 
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2.4. Protein extraction and quantification 148 
 149 
Crude membrane and total protein was extracted from frozen tissue samples (50 mg) 150 
for each horse, as previously described (Lacombe et al., 2003). Briefly, for crude 151 
membrane extraction, tissues were homogenised (BioSpec, OK) in buffer (210 mM 152 
sucrose, 40 mM NaCl, 2 mM EGTA, 30 mM Hepes, with a protease inhibitor 153 
cocktail).  Cells were lysed (1.2 M KCl) prior to ultra-centrifugation at 30,330 x g for 154 
90 min at 4°C.  The pellet was retained and re-suspended in buffer (1 mM EDTA, 10 155 
mM Tris containing 0.33%vol 16% SDS) prior to further centrifugation for 45 min at 156 
3,000 x g. Total protein was extracted by homogenisation in Triton-X-100 extraction 157 
buffer (1% Triton-X-100, 150 mM NaCl, 50 mM of Tris HCl, with a protease 158 
inhibitor cocktail) and centrifugation for 20 min at 800 x g. Protein concentration was 159 
determined in triplicate with the bicinchoninic acid protein assay kit (Pierce, IL) using 160 
bovine serum albumin (BSA) standards (intra-assay CV = 2.1%). Absorbance at 562 161 
nm was measured on a microplate reader (Biotek, VT). 162 
 163 
2.5. Western immunoblotting 164 
 165 
Skeletal muscle and lamellar protein extracts were analyzed for protein content in 166 
total lysates and crude membrane fractions by quantitative Western blotting, as 167 
previously described (Lacombe et al., 2003; Waller et al., 2012). Briefly, equal 168 
amounts of protein (25 µg) were resolved on an 8% (TLR4) or 12% (IL-6, TNF-α, 169 
SOCS3) SDS polyacrylamide gel and then electrophoretically transferred to a 170 
polyvinylidene fluoride membrane (Millipore, USA) with subsequent immunoblotting. 171 
Membranes were blocked with 1-5% non-fat dry milk prior to being incubated with 172 
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primary antibodies: rabbit anti-human TLR4; 1:200 (Santa Cruz Biotechnology, CA), 173 
rabbit anti-human SOCS-3; 1:1000 (Abcam, MA), rabbit anti-equine TNF-α; 1:1000 174 
(Santa Cruz Biotechnology, CA), goat anti-equine Il-6; 1:500 (R&D Systems) at 4°C 175 
for 16 h followed by an appropriately directed secondary antibody conjugated to 176 
horseradish peroxidase. Protein content was assessed by enhanced 177 
chemiluminescence reaction (KPL, MD) and quantified using a Gel-Pro Analyzer blot 178 
scanning and analysis system (Media Cybernetics, MD). The TNF-α and IL-6 179 
antibodies were equine-specific. The SOCS3 and TLR4 antibodies were chosen based 180 
on their protein sequence homology with Equus caballus (100% and 98%, 181 
respectively) and were previously validated for use in the horse (Altschul et al., 1990; 182 
Waller et al., 2012). Antibodies were all validated against a positive control and equal 183 
protein loading was confirmed by re-probing the membranes with rabbit anti-canine 184 
calsequestrin (muscle; 1:2500, Thermo Scientific, DE) or goat anti-human β-actin 185 
(lamellae; 1:1000, Santa Cruz Biotechnology, CA) protein expression following 186 
immunoblotting.  187 
 188 
2.6. Statistical analyses 189 
 190 
The distribution of data residuals was considered normal (Shapiro-Wilk test). The 191 
comparative tissue data did not have equal variance, so was analysed non-192 
parametrically with a Mann-Whitney test. Band densitometry results were analysed 193 
separately for each treatment and tissue type and were compared between treated and 194 
control horses using a t-test. The relationship between lamellar TLR4 and SOCS3 195 
protein expression was assessed with Pearson’s correlation co-efficient. All data are 196 
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expressed as mean ± se and significance was accepted at p < 0.05. Statistical analyses 197 
were performed using SigmaPlot v. 12.3. 198 
 199 
3. Results 200 
 201 
3.1. TLR4 differential protein expression in healthy horses 202 
 203 
Due to the fact that TLR4 has not been characterized in the lamellae of horses, we 204 
first performed a comparison of crude membrane fractions of lamellar tissue and 205 
skeletal muscle from healthy, control horses. TLR4 protein was present in both tissues, 206 
with no difference in protein expression between these two tissue sites (Fig. 1). 207 
 208 
3.2. TLR4 signaling in skeletal muscle  209 
 210 
Next we determined whether marked hyperinsulinaemia could activate TLR4 and 211 
subsequently increase IL-6 and TNF-α expression in insulin-sensitive tissue. Skeletal 212 
muscle samples from horses treated with a p-EHC did not show any change in protein 213 
expression of TLR4 or the pro-inflammatory cytokines IL-6 and TNF-α, when 214 
compared to their matched controls (Fig. 2). Further, SOCS-3 protein expression did 215 
not differ between groups (Fig. 2). 216 
 217 
3.3. TLR4 signaling in lamellar tissue 218 
 219 
The marked hyperinsulinaemia observed in the p-EHC group was associated with an 220 
increase (p < 0.05) in TLR4 protein content in the crude membrane protein fraction 221 
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compared to controls, without a change in the total lysate protein content, consistent 222 
with increased activation of TLR4 signaling (Fig. 3). Lamellar protein content of the 223 
pro-inflammatory cytokine TNF-α was also increased in total lysates from horses 224 
treated with the p-EHC compared to paired control horses, without a change in IL-6 225 
protein content (Fig. 4). Compared to control horses, there was a trend (p = 0.099) 226 
towards an increase in lamellar SOCS3 protein content following a p-EHC (Fig 5.a, b). 227 
Further, lamellar SOCS3 protein content was positively correlated with TLR4 protein 228 
expression in crude membrane fractions (p < 0.05, Fig. 5c). In contrast, lamellar 229 
protein expression of TLR4, IL-6, TNF-α and SOCS-3 did not differ between horses 230 
treated with the p-GI, compared to their matched control horses (Fig. 6). 231 
 232 
4. Discussion  233 
 234 
The p-EHC and p-GI provide well-controlled models for examination of the effects of 235 
both marked and moderate hyperinsulinaemia in otherwise healthy, insulin-sensitive 236 
horses (de Laat et al., 2010; de Laat et al., 2012c). In the current study, the impact of 237 
hyperinsulinaemia on lamellar and skeletal muscle TLR4 expression and pro-238 
inflammatory cytokine dynamics was examined and compared to normoinsulinaemic, 239 
normoglycaemic horses. Previous studies examining insulin-sensitive tissues and 240 
plasma markers of inflammation under hyperinsulinaemic conditions in insulin-241 
sensitive horses have not concurrently examined the lamellae (Suagee et al., 2011a). 242 
Rather, studies have extrapolated whole body levels to the foot. However, our results 243 
suggest that changes occurring in insulin-sensitive tissues, such as skeletal muscle, 244 
may not provide an accurate reflection of lamellar physiology. 245 
 246 
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Current inflammatory profiling data from hyperinsulinaemic horses with IR is 247 
conflicting. While some studies have not found evidence for a chronic inflammatory 248 
state to be present in obese and/or IR horses (Carter et al., 2009; Holbrook et al., 249 
2007), another has shown pro-inflammatory cytokines to be correlated with obesity 250 
and insulin sensitivity (Vick et al., 2007) similar to reports in obese humans with IR 251 
and metabolic syndrome (Tanti et al., 2012). Experimental data has shown that LPS 252 
increases pro-inflammatory cytokine expression and decreases insulin sensitivity in 253 
horses, which not only supports the existence of functional TLR4 signaling pathways, 254 
but suggests that inflammation and metabolism are intertwined in the horse (Toth et 255 
al., 2008; Vick et al., 2008). In support of these findings,  decreased insulin sensitivity 256 
has been associated with increased circulating TNF-α protein in obese mares (Vick et 257 
al., 2007). Further, it has recently been reported that horses with compensated IR had 258 
an increase in TLR4 and SOCS3 protein expression in visceral adipose tissue and 259 
skeletal muscle (Waller et al., 2012). However, the horses in that study were not 260 
hyperinsulinaemic, although they exhibited an abnormal glucose tolerance test. Given 261 
that TLR4, IL-6, TNF-α and SOCS3 expression was not increased in skeletal muscle 262 
by hyperinsulinaemia in the current study these findings suggest that other factors, 263 
such as adiposity, may activate TLR4, TNF-α and SOCS3 expression in insulin-264 
sensitive tissue. Indeed, activation of TLR4 in adipose and cardiac tissue has been 265 
implicated in the pathogenesis of metabolic syndrome and diabetic cardiomyopathy, 266 
respectively, in humans (Chao, 2009; Dong et al., 2012; Tsukumo et al., 2007). In 267 
addition, the family of suppressors of cytokine signaling (SOCS) proteins, which can 268 
be activated secondary to TLR4 signaling, has been suggested to be a crucial key link 269 
between inflammation and hepatic IR in rodents (Zhang et al., 2012). Studies on TLR 270 
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signaling in insulin-sensitive tissues and correlation with lamellar TLR4 and pro-271 
inflammatory cytokine expression is required in obese, hyperinsulinaemic horses. 272 
 273 
In this study, we report that TLR4 protein is expressed in the lamellar tissue of 274 
healthy horses. This is supported by prior data demonstrating that TLR4 signaling is 275 
likely to be present in equine keratinocytes, a finding based on IL responses to 276 
stimulation with LPS (Leise et al., 2010). Interestingly, the lamellar tissue expressed 277 
similar protein concentrations of TLR4 to skeletal muscle under normal conditions, 278 
indicating that inflammatory pathways activated by TLRs are of potential significance 279 
to the lamellar structure as well. Functional TLR signaling in the lamellae may be 280 
particularly important during endotoxaemia and episodes of septic laminitis when 281 
increased circulating LPS is likely to activate TLR4 and contribute to lamellar 282 
inflammation. In addition, considering that free fatty acids can also activate TLR4, 283 
lamellar inflammation resulting from TLR signaling may also be up-regulated during 284 
conditions that increase circulating free fatty acid concentrations, such as obesity 285 
(Dasu et al., 2010). Further, TLRs can activate intracellular signaling pathways also 286 
mediated by insulin, including mitogen activated protein-kinase (MAP-K) and 287 
extracellular signal-regulated kinases (ERK1/2) (Tanti et al., 2012). Thus, the up-288 
regulated lamellar TLR signaling reported in the p-EHC group may exacerbate the 289 
increased epidermal cell growth and proliferation associated with acute 290 
hyperinsulinaemic laminitis, although this is unlikely to be a major contributory factor 291 
to the disease given that TLR4 was not activated in the p-GI (de Laat et al., 2012b). 292 
However, the cellular distribution of TLR4 in the lamellae is unknown and 293 
immunohistochemical analyses would be required to determine if the receptors are 294 
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well-placed to play a role in the demise of the dermo-epidermal interface or if, for 295 
example, they are confined to the vasculature. 296 
 297 
Failure of TLR4 or markers of inflammation to be increased in the lamellae of horses 298 
treated with the p-GI suggests that TLR4 signaling is unlikely to play a developmental 299 
role in hyperinsulinaemic laminitis pathophysiology. The moderate hyperinsulinaemia 300 
induced by the p-GI results in subclinical lamellar pathology consistent with early 301 
developmental phases of acute hyperinsulinaemic laminitis without inducing lameness 302 
(de Laat et al., 2012b; de Laat et al., 2012c). Alongside previous data showing that 303 
infiltration of inflammatory leucocytes is minimal in the insulin-induced model of 304 
laminitis (de Laat et al., 2012b; de Laat et al., 2011b), the current data suggests that 305 
inflammation appears to be a symptom, rather than an initiating factor, of the disease. 306 
However, increases in lamellar TLR4 and TNF-α protein expression at Obel grade 2 307 
laminitis in the p-EHC horses suggests that inflammation has a role to play in latter 308 
stages of hyperinsulinaemic laminitis. Evidence of inflammation may simply be 309 
associated with increasing severity of the laminitis lesion, such as neutrophil 310 
infiltration, or may be a consequence of attempts at repair or remodelling by the 311 
lamellar tissue.  312 
 313 
The up-regulation of TLR4 protein expression at the cell membrane in the lamellae of 314 
horses with acute laminitis in the current study is likely to have contributed to the 315 
increase in lamellar TNF-α concentration. However, extravasated neutrophils around 316 
areas of damaged basement membrane may also account for increased TNF-α release 317 
(de Laat et al., 2011b; Singer and Granger, 2007). By comparison, gene expression 318 
studies showed that TNF-α was not increased in the lamellae of horses with Obel 319 
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grade 1 lameness secondary to dietary CHO (Leise et al., 2011). However, lamellar 320 
IL-6 gene expression was increased at Obel grade 1 lameness (Leise et al., 2011). 321 
Indeed, increased lamellar IL-6 seems to be a ubiquitous finding in both the CHO and 322 
black walnut extract models of laminitis induction (Belknap et al., 2007; Loftus et al., 323 
2007; Waguespack et al., 2004). The reverse pro-inflammatory cytokine profile found 324 
in the current study may be a reflection of the Obel grade of lameness (2 vs. 1) or the 325 
induction method of the laminitis. Interestingly, increases in lamellar IL-6 can 326 
precede neutrophil infiltration during CHO laminitis (Visser, 2008) which may 327 
suggest that mode of laminitis induction is the more critical influential factor over 328 
pro-inflammatory cytokine expression during laminitis. 329 
 330 
Pro-inflammatory cytokine levels in a tissue are controlled by negative feedback 331 
regulation achieved mainly through the SOCS family of proteins (Krebs and Hilton, 332 
2001). Protein expression of SOCS is increased following cytokine-mediated 333 
activation of the janus kinase-signal transducers and activators of transcription 334 
(JAK/STAT) signaling pathways, which then feeds back to inhibit JAK/STAT 335 
signaling (Yoshimura et al., 2012). As such, the SOCS proteins play a key role in 336 
regulating inflammation (Krebs and Hilton, 2001). In addition to its role in 337 
inflammation, SOCS3 inhibits other pathways activated by insulin, including 338 
phosphoinositol-kinase 3 (PI3-K), and contributes to IR via serine phosphorylation of 339 
insulin receptor substrate-1 in other species (Babon and Nicola, 2012; Kim, 2006). In 340 
horses, increased SOCS3 protein expression was significantly correlated with TLR4 341 
content in skeletal muscle of horses with compensated IR, suggesting that the 342 
activation of SOCS3 production, secondary to TLR4 signaling, could also contribute 343 
to equine metabolic dysfunction (Waller et al., 2012). A similar strong correlation 344 
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between lamellar TLR4 and SOCS3 protein concentrations was found in the current 345 
study, which suggests that a negative regulation system for TLR signaling also exists 346 
in the equine lamellae.  347 
 348 
The trend towards an increase in lamellar SOCS3 protein expression during 349 
hyperinsulinaemic laminitis may have occurred secondary to increased JAK/STAT 350 
signaling pathways. It has been shown previously that horses with black walnut 351 
extract or CHO-induced laminitis had increased expression of STAT3 and SOCS3 in 352 
their lamellae at the onset of lameness, which presumably occurred independently of 353 
hyperinsulinaemia (Leise et al., 2012). The role of SOCS proteins in laminitis 354 
pathophysiology is intriguing and requires further elucidation, particularly as their 355 
capability for negative control of inflammation makes them potential therapeutic 356 
candidates for the disease.  357 
 358 
5. Conclusions 359 
Overall, innate immune system pathways appear to be important to laminitis 360 
pathophysiology, although it is unlikely that they contribute significantly to the 361 
developmental pathogenesis of hyperinsulinaemic laminitis. However, their potential 362 
to play a key role in the pathophysiologies associated with altered metabolic states in 363 
the horse, such as hyperinsulinaemia and IR, exists and further investigation is 364 
required to extend this area of research. 365 
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Figures 552 
 553 
 554 
Fig. 1: The protein expression of toll-like receptor 4 (TLR4) was similar in skeletal 555 
muscle and lamellar tissue from normal control horses (n = 4). Top panel:  556 
Representative Western blot from a crude membrane extract. An appropriate loading 557 
control was not available for comparative tissue blots. Bottom panel: Median TLR4 in 558 
skeletal muscle and lamellar tissue from healthy control horses. 559 
 560 
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 561 
Fig 2: Skeletal muscle protein expression of TLR4 signaling parameters did not differ 562 
between control horses (C) and horses treated with a prolonged, euglycaemic 563 
hyperinsulinaemic clamp (p-EHC). Top panels:  Representative Western blot of crude 564 
membrane extracts with calsequestrin as a loading control. Bottom panels: Mean ± se 565 
of TLR4 (A), SOCS3 (B), TNF-α (C) and IL6 (D) protein content in skeletal muscle 566 
from horses treated with a p-EHC, compared to control horses. 567 
 568 
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 569 
Fig. 3: Lamellar protein expression of expression of toll-like receptor 4 (TLR4) was 570 
increased at the crude membrane surface, but not in total protein lysates, in horses 571 
treated with a prolonged, euglycaemic hyperinsulinaemic clamp (p-EHC). Panels A 572 
and C: Representative Western blot of crude membrane extracts with actin as a 573 
loading control. Panel B: Lamellar TLR4 protein was increased in horses treated with 574 
a p-EHC, compared to control horses (*, p < 0.05). Panel D: Lamellar total TLR4 575 
protein content did not differ between the p-EHC and control groups. 576 
 577 
 578 
Fig 4: Lamellar TNF-α and IL-6 protein content in horses treated with a prolonged, 579 
euglycaemic hyperinsulinaemic clamp (p-EHC). Panels A and C: Representative 580 
Western blot of crude membrane extracts with actin as a loading control. Panel B: 581 
 23 
TNF-α protein content was increased in horses treated with a p-EHC, compared to 582 
control horses (*, p < 0.05). Panel D: Protein expression of interleukin-6 (IL-6) was 583 
not significantly different between p-EHC treated and control horses. 584 
 585 
 586 
Fig. 5: Lamellar protein content of suppressor of cytokine signaling 3 (SOCS3) in 587 
horses treated with a prolonged, euglycaemic hyperinsulinaemic clamp (p-EHC), 588 
compared to controls. Panel A: Representative Western blot of SOCS3 in crude 589 
membrane extracts with loading control (actin). Panel B.  Mean ± se of SOCS3 590 
protein content trended (p = 0.099) towards being increased in p-EHC treated horses. 591 
Panel C: Linear regression demonstrated that TLR4 content (independent variable) 592 
was positively correlated with SOCS3 content (dependent variable) in both control (□) 593 
and p-EHC horses (■).  (y = 1.78x – 3.47, p < 0.01, Rsqr = 0.88). 594 
 595 
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 596 
Fig 6: Lamellar protein expression of TLR4, TNF-α, IL-6 and SOCS-3 did not differ 597 
between control horses and horses treated with a prolonged, glucose infusion (p-GI). 598 
Top panels:  Representative Western blot in crude membrane extracts with actin as a 599 
loading control. Bottom panels: Mean ± se of TLR4 (A), SOCS3 (B), TNF-α (C) and 600 
IL-6 (D) in lamellar tissue from horses treated with a p-GI, compared to control 601 
horses. 602 
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